Previous close | 143.55 |
Open | 140.70 |
Bid | 139.05 x 100000 |
Ask | 139.65 x 50000 |
Day's range | 138.95 - 140.70 |
52-week range | 131.55 - 195.80 |
Volume | |
Avg. volume | 7 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Alnylam Pharmaceuticals, Inc. ( NASDAQ:ALNY ) just released its latest first-quarter results and things are looking...
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript May 2, 2024 Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.52272, expectations were $-0.75. ALNY isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for […]
Alnylam (ALNY) reports better-than-expected first-quarter 2024 results as both earnings and revenues beat estimates, primarily driven by strong Amvuttra sales.